Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection

HIV Medicine

Volumn 3, Issue 4, 2002, Pages 263-270

  Wilson, I B ^a   Jacobson, D L ^b   Roubenoff, R ^a,b,c   Spiegelman, D ^d   Knox, T A ^a   Gorbach, S L ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS wasting; Body composition; Health status; HIV disease; Lean body mass; Quality of life

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; CELL COUNT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEAN BODY WEIGHT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SELF REPORT; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH STATUS; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 0036813709     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1293.2002.00122.x     Document Type: Article

References (43)

1. Guenter P, Muurahainen N, Simons G et al. Relationships among nutritional status, disease progression, and survival in HIV infection. J Acquir Immune Defic Syndr 1993; 6: 1130-1138.
2. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med 1989; 320: 1388-1393.
3. Palenicek JP, Graham NM, He YD et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr 1995; 10: 366-373.
4. Kotler DP, Tierney AR, Wang J et al. The magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutrit 1989; 50: 444-447.
5. Lindan CP, Allen S, Serufilira A et al. Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med 1992; 116: 320-328.
6. Suttmann U, Ockenga J, Selberg O et al. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr 1995; 8: 239-246.
7. Chlebowski RT, Grosvenor MB, Bernhard NH, Morales LS, Bulcavage LM. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989; 84: 1288-1293.
8. Wheeler DA, Gibert CL, Launer CA et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr 1998; 18: 80-85.
9. Testa MA, Lenderking WR. The impact of AIDS-associated wasting on quality of life: qualitative issues of measurement and evaluation. J Nutr 1999; 129: 282S-9S.
10. Wilson IB, Cleary PD. Clinical predictors of physical function in persons with acquired immune deficiency syndrome. Med Care 1996; 34: 610-623.
11. Wilson IB, Cleary PD. Clinical predictors of declines in physical functioning in persons with AIDS. Results of a longitudinal study. J Acquir Immune Defic Syndr 1997; 16: 343-349.
12. Von Roenn JH, Armstrong D, Kotler DP et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994; 121: 393-399.
13. Oster MH, Enders SR, Samuels SJ et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med 1994; 121: 400-408.
14. Schambelan M, Mulligan K, Grunfeld C et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996; 125: 873-882.
15. Hengge UR, Baumann M, Maleba R, Brockmeyer NH, Goos M. Oxymetholone promotes weight gain in patients with advanced human immunodeficiency virus (HIV-1) infection. Br J Nutr 1996; 75: 129-138.
16. Gold J, High HA, Li Y et al. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS 1996; 10: 745-752.
17. Melchior JC, Chastang C, Gelas P et al. Efficacy of 2-month total parenteral nutrition in AIDS patients: a controlled randomized prospective trial. The French Multicenter Total Parenteral Nutrition Cooperative Group Study. AIDS 1996; 10: 379-384.
18. Miller K, Corcoran C, Armstrong C et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metabolism 1998; 83: 2717-2725.
19. Waters D, Danska J, Hardy K et al. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996; 125: 865-872.
20. Grinspoon S, Corcoran C, Askari H et al. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 129: 18-26.
21. Strawford A, Barbieri T, Van Loan M et al. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA 1999; 281: 1282-1290.
22. Grinspoon S, Corcoran C, Parlman K et al. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 2000; 133: 348-355.
23. Grinspoon S, Corcoran C, Miller K et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting [published erratum appears in J Clin Endocrinol Metab 1997; 82: 3360]. J Clin Endocrinol Metabolism 1997; 82: 1332-1337.
24. Kotler DP, Thea DM, Heo M et al. Relative influences of sex, race, environment, and HIV infection on body composition in adults. Am J Clin Nutrit 1999; 69: 432-439.
25. Wilson IB, Roubenoff R, Knox TA, Spiegelman D, Gorbach SL. Relation of lean body mass to health-related quality of life in persons with HIV. J Acquir Immune Defic Syndr 2000; 24: 137-146.
26. Shevitz AH, Knox TA, Spiegelman D, Roubenoff R, Gorbach SL, Skolnik PR. Elevated resting energy expenditure among HIV-seropositive persons receiving highly-active antiretroviral therapy. AIDS 1999; 13: 1351-1357.
27. Silva M, Skolnik PR, Gorbach SL et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12: 1645-1651.
28. Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000; 95: 3482-3489.
29. Wanke CA, Silva M, Knox TA, Forrester J, Spiegelman D, Gorbach SL. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31: 803-805.
30. Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr 1995; 8: 253-265.
31. Lukaski HC. Use of bioelectric impedance analysis to assess human body composition: a review. In: Livingston, GE, ed. Nutritional Status Assessment of the Individual. Trumbull, CT, Food and Nutrition Press, 1989: 189-204.
32. Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness. measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77-97.
33. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988; 26: 775-789.
34. Sallis JF, Haskell WL, Wood PD et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985; 121: 91-106.
35. Diggle PJ, Liang K-J, Zegar SL. Analysis of Longitudinal Data. Oxford: Clarendon Press, 1994.
36. Cook RD, Weisberg G. Residuals and Influence in Regression. New York: Chapman & Hall, 1982.
37. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561.
38. Forrester JE, Spiegelman D, Tchetgen E, Knox TA, Gorbach SL. Weight loss and body composition changes in men and women infected with the HIV virus. Am J Clin Nutrit 2002: in press.
39. Wilson IB. Health-related quality of life and HIV-related nutritional problems. In: Miller, TL, Gorbach, SL, eds. Nutritional Aspects of HIV Infection. New York: Oxford University Press Inc., 2001: 97-108.
40. Bhasin S. The dose-dependent effects of testosterone on sexual function and on muscle mass and function. Mayo Clin Proc 2000; 75 (Suppl): S70-S75.
41. Roubenoff R, Wilson IB. Effect of resistance training on self-reported physical functioning in HIV-infected adults. Med Sci Sports Excerc 2001; 33: 1811-1817.
42. Bioelectrical Impedance Analysis (Supplement). Am J Clin Nutr 1996; 64(Suppl. 3): 387-532.
43. Deurenberg P. Limitations of the bioelectrical impedance method for the assessment of body fat in severe obesity. Am J Clin Nutr 1996; 64: 449S-452S.